MedPath

Characteristics of retinal oxygen saturation in patients with retinal vein occlusio

Phase 1
Not yet recruiting
Conditions
Retina
Registration Number
ITMCTR1900002396
Lead Sponsor
Chengdu University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients with retinal vein occlusion;
(2) Comply with the syndrome differentiation standard of TCM qi stagnation and blood stasis syndrome, liver yang stagnation syndrome, phlegm and blood stasis syndrome, and Yin deficiency fire phlegm syndrome;
(3) The best corrected visual acuity (BCVA) of the target eye is =34 points (the ETDRS visual acuity chart, the visual acuity is equivalent to a score of 20/200, and the decimal is 0.1);
(4) Those with an onset within 3 months;
(5) Aged between 18 and 65 years;
(6) After fully communicating with the patient, the patient voluntarily joined the study and signed the informed consent form.

Exclusion Criteria

(1) Accompanied by other fundus diseases (such as retinal vein inflammation, glaucoma, diabetic retinopathy, macular degeneration, optic nerve disease, etc.);
(2) Opacity of refractive medium is difficult to perform fundus image evaluation;
(3) Patients with severe hematopoietic diseases and mental disorders;
(4) Pregnant or lactating women;
(5) Those who are allergic to the compound tropicamide eye drops;
(6) Those who have participated in other clinical trials in the past 3 months.

Study & Design

Study Type
Basic Science
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.